Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1807534-86-6
518044-35-4
518044-37-6
2055048-43-4
518044-36-5
2250216-91-0
2112734-70-8 | N-(Hydroxy-peg3)-n-bis(peg4-t-butyl ester) | AA019EAV | MFCD30730366
654651-21-5 | BDP 581/591 NHS ester | AA019EFH | MFCD31580123
40649-26-1 | N-Cyclopentylaniline | AA019EJ1 | MFCD09608069
41102-02-7 | 7-bromo-1H-thieno[3,2-d]pyrimidine-2,4-dione | AA019ELR | MFCD11869288
1285530-55-3 | N-(4-Bromopyridin-2-yl)propionamide | AA019EP7 | MFCD23131207
1161864-92-1 | 2-(Phenylsulfonyl)nicotinaldehyde | AA019ESB | MFCD29917041
172992-35-7 | (S)-3-(4-(Benzyloxy)Phenyl)-2-Butyramidopropanoic Acid | AA019EVU | MFCD30471758
630119-99-2 | 1-PIPERIDINECARBOXYLIC ACID, 4-HYDROXY-4-(2-THIENYL)-, 1,1-DIMETHYLETHYL ESTER | AA019EYP | MFCD30294433
5945-33-5 | Tetraphenyl (propane-2,2-diylbis(4,1-phenylene)) bis(phosphate) | AA019FSA | MFCD09753077
1227575-01-0 | 4-(bromomethyl)-2-chloro-6-(trifluoromethyl)pyridine | AA019GBP | MFCD16610143